No supplier or customer ties in ACHV's filings yet. The map draws only what companies disclose to the SEC; ties named in other companies' filings join as the graph reads them.
Achieve Life Sciences, Inc., a clinical-stage pharmaceutical company, develops and commercializes of cytisinicline for smoking cessation and nicotine addiction in Canada, the United States, and the United Kingdom. The company offers cytisinicline, a plant-based alkaloid that interacts with nicotine receptors in the brain that reduce the severity of nicotine withdrawal symptoms. It has license agreements with Sopharma AD and University of Bristol. The company is based in Vancouver, Canada.
Nothing on the wire mentions ACHV yet. Iris sweeps the public feeds every quarter hour; headlines land here the moment a sweep tags them.
How ACHV has moved on past release days vs its typical ±3.2% day, and how often it closed up. Computed from daily closes — not a forecast.